Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vaccines, social measures and Covid19 - A European evidence-based analysis Vaccines, social measures and Covid19

View through CrossRef
ABSTRACTBackgroundA fully quantitative picture of national effectiveness in controlling the spread of the Covid19 virus should consider the percentage of a population vaccinated in relation to the percentage of a population as active cases.MethodsPublicly available data from 27 European countries on nine dates in 2021. Data were (i) initial Covid19 vaccinations and (ii) Covid19 active cases, both as percentages of a country’s population. Dividing (i) by (ii) yielded a new metric, the V ratio, which can increase as (i) increase or as (ii) decreases or both. I correlated the change in V ratio with the change in R statistic in the 27 counties and nine dates.ResultsMean European V ratio increased from January 11 2021 onwards; inverse correlation was found between V ratio and R statistic (p<0.001, r2=0.15, df=234). Initial threshold V ratio of 10-15 resulted in an R statistic of 1.0 or lower; this threshold increased to 30-40 with further vaccinations. Variation between countries in the V ratio increased with time.ConclusionThis quantitative assessment and use of a summary data-derived threshold index showed the integrated effectiveness of vaccinations and social measures for European countries for Covid19. It established a threshold range for an R value of 1 and calculation of the number of vaccinations needed in Europe to reduce the infectivity of the virus to unity. Results can be used to quantify the relation between transmission following vaccination and social measures to control the spread of Covid19.Summary box‘What is already known’ in the epidemiology of the Covid19 pandemic in Europe countries is time- and country-based estimates of the R statistic as a measure of infectivity, the percentages of vaccinated persons to reduce infectivity and the number of active cases amenable to social measures. What is not known is how these three parameters interact.What does this study add’? This study adds by invention an index (V) of percentage vaccinated population divided by percentage active cases. It then examines the corresponding V index in relation to the R statistic. It derives a range threshold V ratio for an R statistic of unity and extends this to suggest the total number of vaccines needed in Europe.Policy implicationsThese results will allow policy judgements to be made on the basis of measured evidence, and not just models, of the means to reduce the Covid19 pandemic in Europe. The R statistic captures the development of the pandemic; the V ratio measures the integrated and quantified measures to reduce it. Further development of the analysis could assist in calculating the relative effectiveness of vaccination and social measures linked to a range of values of the V ratio. It can also be used as an alarm call to identify states which, even given 100% vaccination, may not reduce their R statistic below unity.
Cold Spring Harbor Laboratory
Title: Vaccines, social measures and Covid19 - A European evidence-based analysis Vaccines, social measures and Covid19
Description:
ABSTRACTBackgroundA fully quantitative picture of national effectiveness in controlling the spread of the Covid19 virus should consider the percentage of a population vaccinated in relation to the percentage of a population as active cases.
MethodsPublicly available data from 27 European countries on nine dates in 2021.
Data were (i) initial Covid19 vaccinations and (ii) Covid19 active cases, both as percentages of a country’s population.
Dividing (i) by (ii) yielded a new metric, the V ratio, which can increase as (i) increase or as (ii) decreases or both.
I correlated the change in V ratio with the change in R statistic in the 27 counties and nine dates.
ResultsMean European V ratio increased from January 11 2021 onwards; inverse correlation was found between V ratio and R statistic (p<0.
001, r2=0.
15, df=234).
Initial threshold V ratio of 10-15 resulted in an R statistic of 1.
0 or lower; this threshold increased to 30-40 with further vaccinations.
Variation between countries in the V ratio increased with time.
ConclusionThis quantitative assessment and use of a summary data-derived threshold index showed the integrated effectiveness of vaccinations and social measures for European countries for Covid19.
It established a threshold range for an R value of 1 and calculation of the number of vaccinations needed in Europe to reduce the infectivity of the virus to unity.
Results can be used to quantify the relation between transmission following vaccination and social measures to control the spread of Covid19.
Summary box‘What is already known’ in the epidemiology of the Covid19 pandemic in Europe countries is time- and country-based estimates of the R statistic as a measure of infectivity, the percentages of vaccinated persons to reduce infectivity and the number of active cases amenable to social measures.
What is not known is how these three parameters interact.
What does this study add’? This study adds by invention an index (V) of percentage vaccinated population divided by percentage active cases.
It then examines the corresponding V index in relation to the R statistic.
It derives a range threshold V ratio for an R statistic of unity and extends this to suggest the total number of vaccines needed in Europe.
Policy implicationsThese results will allow policy judgements to be made on the basis of measured evidence, and not just models, of the means to reduce the Covid19 pandemic in Europe.
The R statistic captures the development of the pandemic; the V ratio measures the integrated and quantified measures to reduce it.
Further development of the analysis could assist in calculating the relative effectiveness of vaccination and social measures linked to a range of values of the V ratio.
It can also be used as an alarm call to identify states which, even given 100% vaccination, may not reduce their R statistic below unity.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Vaccine Types
Vaccine Types
Vaccines are biological preparations, often made from attenuated or killed forms of microorganisms or fractions thereof. They work by stimulating the immune system to produce anti...
Adverse effects of COVID-19 vaccines in university students
Adverse effects of COVID-19 vaccines in university students
Background Existing data on adverse effects of coronavirus disease 2019 (COVID-19) vaccines among university students are limited. This study aimed to investigate the characteristi...
FACTORES SOCIALES ASOCIADOS A LA VACUNACIÓN DE COVID19 EN ECUADOR
FACTORES SOCIALES ASOCIADOS A LA VACUNACIÓN DE COVID19 EN ECUADOR
Introducción El 31 de diciembre de 2019, la República Popular China notificó un grupo de casos de neumonía de etiología desconocida que posteriormente fueron identificados el 09 de...
Traditional and Recent Approaches for the Development of Animal Vaccines. A Review
Traditional and Recent Approaches for the Development of Animal Vaccines. A Review
Objective: To show new trends in the field of vaccinology and spread awareness among population regarding vaccination of animals and successfully controlling spread of diseases Stu...
Recent Advances in mRNA Vaccine Development
Recent Advances in mRNA Vaccine Development
Traditional vaccines are produced by using weakened or inactivated forms of disease-causing pathogens to produce the target antigen they are designed to protect against. Messenger ...

Back to Top